Search Login Register

leflunomide (Arava) Summary

536 relevant articles (77 outcomes, 103 trials/studies) found for this Drug

Description: inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway; antagonizes growth-factor mediated smooth muscle cell proliferation in vitro; structure given in first source

Also Known As: Arava; SU101; Aventis Behring Brand of Leflunomide; Aventis Brand of Leflunomide; Aventis Pharma Brand of Leflunomide Show All >>

Key Diseases for which leflunomide is Relevant

  1. Rheumatoid Arthritis : 33 outcomes 57 studies in 301 results
  2. Autoimmune Diseases (Autoimmune Disease) : 7 outcomes 1 study in 20 results
  3. Psoriasis (Pustulosis Palmaris et Plantaris) : 6 outcomes 5 studies in 9 results
  4. Arthritis (Polyarthritis) : 3 outcomes 3 studies in 26 results
  5. Disease Progression : 3 outcomes 3 studies in 12 results
Show All >>

Drugs Related to leflunomide

  1. Methotrexate (Mexate)
  2. infliximab (Remicade)
  3. leflunomide (Arava)
  4. pyrimidine
  5. Sulfasalazine (Azulfidine)
  6. azastene
  7. Cyclosporine (Ciclosporin)
  8. Tacrolimus (Prograf)
  9. Cyclophosphamide (Cytoxan)
  10. Prednisone (Sone)
Show All >>

Therapies Related to leflunomide

  1. Heterologous Transplantation (Xenotransplantation)
  2. Transplants (Transplant)
  3. Drug Therapy (Chemotherapy)
  4. Organ Transplantation
  5. Transplantation (Transplant Recipients)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.